-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Post-transcriptional Mechanisms

Symposia: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies Program: Scientific Workshops
Friday, December 6, 2024: 2:44 PM-3:25 PM
Room 33 (San Diego Convention Center)
Moderator:
and Christina Glytsou, PhD, Rutgers University
Disclosures:
No relevant conflicts of interest to declare.

RNA splicing, RNA stability, post-transcriptional modifications and associated mechanisms will be discussed in this session. This session will also focus on the role of the interaction of tumor cell with the microenvironment and immune system in disease resistance and the impact of aberrant splicing and epitranscriptomics on these interactions.
Moderator Introduction

Christina Glytsou, PhD

Rutgers University, Piscataway, NJ
RNA Modification and Therapy Resistance in Acute Leukemia

Jianjun Chen, PhD

City of Hope Comprehensive Cancer Center, Duarte, CA
Exploiting Epitranscriptomic Vulnerabilities: M6a and Splicing Factor Mutations in Myelodysplastic Syndrome (MDS)/Leukemia

Stephanie Halene, MD

Yale Univ. School of Medicine, New Haven, CT; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
Targeting Casitas B-lineage Lymphoma (CBL) Mutant Myeloid Malignancies

Wei Tong, PhD

Children's Hospital of Philadelphia, Philadelphia, PA
Panel Discussion
See more of: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
See more of: Scientific Workshops
<< Previous Session | Next Session >>